Synektik Spólka Akcyjna stock
Price history
+18.38% over the period1 year: from zł 260.00 (November 20, 2025) to zł 307.80 (November 20, 2026), +18.38%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 20, 2026 | zł 307.80 |
| October 30, 2026 | zł 327.00 |
| September 30, 2026 | zł 353.20 |
| August 31, 2026 | zł 335.00 |
| July 31, 2026 | zł 362.00 |
| June 30, 2026 | zł 333.00 |
| May 29, 2026 | zł 272.60 |
| April 30, 2026 | zł 287.20 |
| March 31, 2026 | zł 293.20 |
| February 27, 2026 | zł 300.00 |
| January 30, 2026 | zł 295.00 |
| December 30, 2025 | zł 282.60 |
| November 28, 2025 | zł 281.00 |
| November 20, 2025 | zł 260.00 |
At a glance
The company
Provides medical equipment, IT solutions and radiopharmaceutical products for surgery, diagnostic imaging and nuclear medicine in Poland
Latest results
Quarter to June 30, 2026 · EPS zł 19.82
Next event
TickerLandia's take on Synektik Spólka Akcyjna
- Priced as usual relative to earnings: P/E on the latest fiscal year 21 vs a median of 19 over its last 10 fiscal years.
- Cheaper than similar companies: trailing 12-month P/E 16 vs 29 (−45%) in a group of 10.
- Strong point: Growth (96/100 in its group). Weak point: Earnings stability (31/100).
- “Most upside for analysts” (Poland): No. 8 of 23.
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−22.74% from the 52-week high
Analysts · 5 analysts
Average targetzł 373.00+21.18% vs. price
Buy 4 · Hold 1 · Sell 0 · Buy
TickerLandia Fingerprint: Synektik Spólka Akcyjna
Compared with similar companies: very high growth.
Financials and price compared with 31 companies in the medical devices industry, worldwide. Momentum and risk compared with 1,160 European stocks.
Priceaverage44
How much it costs relative to what it produces.
Metric Value Position in group P/E (trailing 12 months) 14.6 2 Forward P/E 26.2 78 EV/EBITDA 11.0 12 Price/book 12.4 92 Price/sales 2.85 37 Profitabilityhigh77
How much it earns on revenue and capital.
Metric Value Position in group Gross margin 35.1% 2 Net margin 44.8% 98 ROE 217.6% 98 ROA 29.2% 98 Operating margin 24.1% 89 Earnings stabilitylow31
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 7.2% 5 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 56 Growthvery high96
How fast revenue and earnings are growing.
Metric Value Position in group Earnings growth (year over year) +132.40% 92 Revenue growth (year over year) +89.50% 98 Average revenue growth (3 years) +59.85% 98 Financial strengthhigh62
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Net debt/EBITDAcounts in reverse: lower means more financial strength · more cash than debt −0.29 72 Debt/equitycounts in reverse: lower means more financial strength 0.19 69 Interest coverage 67.4 75 Current ratio 1.46 31 Dividendhigh75
How much it returns to shareholders, and for how long.
Metric Value Position in group Payout ratiopays out more than its earnings 256.0% 93 Consecutive dividend years 7 years 38 Dividend yield 3.4% 93 Market momentumaverage54
How the stock has moved compared with the market.
Metric Value Position in group 1-year return +18.38% 64 Distance from 200-day average −3.54% 43 Riskaverage43
How much the price swings.
Metric Value Position in group Maximum drawdown (12 months) 21.9% 40 Volatility (60 days) 26.5% 46
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Synektik Spólka Akcyjna is priced as in the past and cheaper than similar companies
On the latest fiscal year's earnings (2025), Synektik Spólka Akcyjna's P/E today is 20.8, in line with the median of its last 10 fiscal years (19.4; between 9.85 and 124.5 from 2016 to 2025). Synektik Spólka Akcyjna's P/E (trailing 12 months): 15.9, −45% against the median of a group of 10 similar companies (28.9).
Compared with 10 similar companies
| Metric | Synektik Spólka Akcyjna | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 15.9 | Low | |
| Forward P/E | 25.9 | Middle | |
| Operating margin | 23.3% | High | |
| ROE | 177.8% | High | |
| Debt/equity | 0.17 | Middle |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Synektik Spólka Akcyjna. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
zł 292.26M
Latest quarter · Q2 2026
Net income
zł 55.08M
Latest quarter · Q2 2026
Quarterly net margin
18.8%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- zł 2.63B
- P/E
- 15.9
- EPS
- zł 19.41
- Volume
- 41.58K
- Daily trading
- €2.24M
- Dividend yield
- 3.49%
- Last ex-dividend on January 28, 2026
How Synektik Spólka Akcyjna is changing
All resultsRevenue grew 40.3% a year on average over the last 5 years
Operating margin rose from 6.9% to 23.3%
Free cash flow equal to 81% of net income
Returns
Synektik Spólka Akcyjna returns with dividends
zł 1,000 invested in Synektik Spólka Akcyjna 5 years ago, on November 22, 2021, would be worth zł 14,515 today with dividends reinvested: +1,351.49% in total, +70.86% per year. On price alone it would be zł 11,092 (+1,009.19%).
| Period | Synektik Spólka Akcyjna | zł 1,000 becomes |
|---|---|---|
| 1 month | −11.96% | zł 880 |
| 6 months | +9.15% | zł 1,091 |
| Year to date | +8.92% | zł 1,089 |
| 1 year | +41.74% | zł 1,417 |
| 3 years | +440.68% | zł 5,407 |
| 5 years | +1,351.49% | zł 14,515 |
| 10 years | +1,952.00% | zł 20,520 |
From 1 year up with dividends reinvested, before taxes; under a year price only. Calculate your investment
The chart in detail
Synektik Spólka Akcyjna: technical analysis
Synektik Spólka Akcyjna shows no clear trend: the price and its 50- and 200-session averages are not aligned. The price is 21.9% below its all-time closing high (zł 394.00, July 15, 2026).
- Trend
- No clear trend
- RSI (14 sessions)
- 35
- Between 30 and 70
- vs 200-session average
- −3.54%
Support and resistance
Price areas where Synektik Spólka Akcyjna has stopped several times in the last year. They describe the chart; they are not forecasts.
- Resistancezł 331.07+7.56%3 touches, last on October 15, 2026
- Resistancezł 319.20+3.70%3 touches, last on September 2, 2026
- Resistancezł 309.95+0.70%4 touches, last on November 2, 2026
- Last pricezł 307.80
- Supportzł 302.00−1.88%2 touches, last on February 27, 2026
- Supportzł 288.55−6.25%4 touches, last on May 21, 2026
- Supportzł 258.73−15.94%3 touches, last on June 1, 2026
Volatility and risk
- Volatility (60 sessions, annualised)
- 26.5%
- Largest fall in the last year
- −21.88%
Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Synektik Spólka Akcyjna: seasonality
Average monthly price change over 16 years
Over the last 16 years, the strongest month for Synektik Spólka Akcyjna has been February: +7.30% on average, positive in 7 years out of 15. The weakest has been August: −3.21% on average, positive in 5 years out of 15. November, the current month, has been positive in 7 years out of 15 (+1.27% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +7.16% | +4.79% | 12 of 15 |
| February | +7.30% | −0.29% | 7 of 15 |
| March | +1.93% | +3.61% | 9 of 15 |
| April | +1.43% | +1.32% | 8 of 15 |
| May | +0.38% | −1.33% | 4 of 15 |
| June | +2.66% | −1.18% | 5 of 15 |
| July | +4.42% | −0.08% | 6 of 15 |
| August | −3.21% | −0.87% | 5 of 15 |
| September | +2.20% | −0.57% | 7 of 16 |
| October | +2.42% | +3.76% | 10 of 16 |
| November | +1.27% | 0.00% | 7 of 15 |
| December | +3.14% | +0.57% | 8 of 15 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Synektik Spólka Akcyjna and its competitors
Synektik Spólka Akcyjna is known for radiopharmaceuticals used in oncology diagnostics, which it researches, produces and sells in Poland. The company also sells medical equipment for diagnostics, therapy and nuclear medicine, and develops IT solutions used in radiology. Its services for surgery, diagnostic imaging and nuclear medicine include maintenance of medical equipment, acceptance tests and specialist tests. Its range combines hardware, software, radiopharmaceuticals and technical services, and its activities are concentrated in Poland.
- Headquarters
- Warsaw, Poland
- Employees
- 231
- Founded
- 2001
- Chief executive
- Cezary Kozanecki
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Synektik Spólka AkcyjnaSNT | $647.15M | 23.3% | 15.9 | +9.15% |
| Revenio GroupREG1V | $428.87M | 14.1% | 25.1 | −35.70% |
| El.En.ELN | $1.44B | 14.7% | 20.7 | +10.78% |
| ChemoMetecCHEMM | $1.75B | 49.1% | 59.9 | +99.42% |
| ElektaEKTA.B | $2.27B | 9.2% | — | +1.17% |
| Medacta GroupMOVE | $2.41B | 15.2% | 27.7 | −30.49% |
Same industry or related industries, similar size. Compare Synektik Spólka Akcyjna with its competitors · Full profile
More on Synektik Spólka Akcyjna
- Synektik Spólka Akcyjna revenue and financials
- Synektik Spólka Akcyjna dividend and valuation
- Synektik Spólka Akcyjna stock return
- Synektik Spólka Akcyjna employees, headquarters and business
